Abstract
Successful treatment depends on the right medicament being prescribed for a specific disorder. When treating climacteric and post-climacteric complaints, the prescribing physician will be guided by the symptoms presented and by the character of the patient-the type of woman she is-when he is selecting the drug, the dose, the mode of administration, and the frequency of administration. Thereafter, the medication should be continued as long as is necessary, but no longer than is sensible.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Burch, J. C., Byrd, B. F. and Vaughn, W. K. (1975). The effects of long-term estrogen administration to women following hysterectomy. In: Estrogens in the Post-menopause P. A. van Keep and C. Lauritzen, eds.), Front. Hormone Res., 3, pp. 208–214. (Basel: Karger)
Gray, L. A., Christopherson, W. M. and Hoover, R. N. (1977). Estrogens and endometrial cancer. Obstet. Gvneeol. 49, 385
Horwitz, R. I. and Feinstein, A. R. (1977). New methods of sampling and analysis to remove bias in case-control research: no association found for estrogens and endometrial cancer. Clin. Res., 25, 459
Lauritzen, C. (1976). Oestrogens and endometrial cancer. In: Clinics in Obstetrics and Gynaecology (R. B. Greenblatt and J. W. YV. Studd, eds.), Vol. 4, pp. 145 167. (London: YV. B. Saunders)
Lauritzen, C. (1978). Management of the patient at risk. In: Estrogen Therapy--The Benefits and Risks (C. Lauritzen and P. A. van Keep, eds.), Front. Hormone Res., Vol. 5, pp. 230–247. (Basel: Karger)
Lauritzen, C., Wolf, A. S. and Strabl, M. (1977). A retrospective study concerning postmenopausal estrogen therapy and endometrial cancer. In: Proceedings of the Second International Meeting on Endometrial Cancer and Related Topics (M.J. Brush, R. W. Taylor and R.J. King, eds.). (London: Ballière Tindall)
Lemon, H. M. (1978). Clinical and experimental aspects of the anti-mammary carcinogenic activity of estriol. In: Estrogen Therapy—The Benefits and Risks (C. Lauritzen and P. A. van Keep, eds.), Front. Hormone Res., Vol. 5, pp. 155–173. (Basel: Karger)
Lindsay, R., Hart, D. M., Aitken, J. M., McDonald, E. B., Anderson, J. B. and Clarke, A. (1976). Long-term prevention of post-menopausal osteoporosis by oestrogen. Lancet, i, 1038
Mack, T. M., Pike, M. C., Henderson, B. E., Pfeffer, R. J., Gerkins, V. R., Arthur, M. and Brown, S. E. (1976). Estrogens and endometrial cancer in a retirement community. N. Engl. J. Med., 294, 1262
Nachtigall, L., Nachtigall, R. M., Nachtigall, R. B. and Beckman, E. M. (1976). Oestrogens and endometrial carcinoma. N. Engl. J. Med., 294, 848
Pfleiderer, A. (1977). Risk factors for endometrial cancer. In: Proceedings of the Second International Meeting on Endometrial Cancer and Related Topics (M. J. Brush, R. W. Taylor and R.J. King, eds.). (London: Balliere Tindall)
Rauramo, L. (1977). Oestrogen therapy and endometrial cancer. In: Proceedings of the Second International Meeting on Endometrial Cancer and Related Topics (M. J. Brush, R. W. Taylor and R.J. King, eds.). (London: Ballière Tindall)
Smith, D. C., Prentice, R., Thompson, D. J. and Hermann, W. L. (1975). Association of exogenous estrogens and endometrial carcinoma. V. Engl. J. Med., 293,1164
Utian, W. H. (1978). Application of cost-effectiveness analysis to post-menopausal estrogen therapy. In: Estrogen Therapy — The Benefits and Risks (C. Lauritzen and P. A. van Keep, eds.), Front Hormone Res., Vol. 5, pp. 26–40. (Basel: Karger)
Uyttenbroeck, F. and Wauters, ?. ?. (1976). L’influence des contraceptives oraux, des progestogènes et des oestrogènes dans la genèse des lésions precancéreuses et cancéreuses de l’appareil genital et du skin. Presented before the Soc. Belge-Pays-Bas d’Obstét. et Gynéc. Antwerp
Ziel, H. K. and Finkle, W. D. (1975). Increased risk of endometrial carcinoma among users of conjugated estrogens. N. Engl. J. Med., 293, 1167
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1979 MTP Press Limited
About this chapter
Cite this chapter
Lauritzen, C. et al. (1979). Management of the patient including the high-risk patient. In: van Keep, P.A., Serr, D.M., Greenblatt, R.B. (eds) Female and Male Climacteric. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-9720-5_11
Download citation
DOI: https://doi.org/10.1007/978-94-011-9720-5_11
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-011-9722-9
Online ISBN: 978-94-011-9720-5
eBook Packages: Springer Book Archive